Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission

Although many cancer patients use complementary and alternative medicine, including Agaricus blazei Murill (ABM), safety is not yet well understood. Cancer survivors took 1.8, 3.6, or 5.4 g ABM granulated powder (Kyowa Wellness Co., Ltd., Tokyo, Japan) per day orally for 6 months. Adverse events wer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ohno, Satoshi, Sumiyoshi, Yoshiteru, Hashine, Katsuyoshi, Shirato, Akitomi, Kyo, Satoru, Inoue, Masaki
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3092499/
https://ncbi.nlm.nih.gov/pubmed/21584278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/192381
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars